Cyclopharm reports record sales, progress in the US
Radiopharmaceutical company Cyclopharm has reported record sales of its equipment and consumables and progress in securing approval for its Technegas technologies to be sold in the United States. The leading producer of lung imaging products reported record revenues in FY 21 in the range of between $17.5 million and $18 million, a rise of more…
Details